렌티바이러스 벡터 시장 보고서(2026년)

A lentiviral vector is a type of viral vector derived from lentiviruses, a subgroup of retroviruses known for their ability to integrate genetic material into the DNA of the host cell genome. These vectors are widely used in molecular biology and gene therapy to deliver genetic material into target cells for purposes such as gene expression, gene silencing, or genetic modification.

The main types of products in the lentiviral vector category include kits, reagents, and consumables. Lentiviral vector kits provide a complete set of tools and components necessary for the production and manipulation of lentiviral vectors. They are used for various applications, including cancer, genetic disorders, infectious diseases, veterinary diseases, and others, and serve a range of users such as biotechnology companies, pharmaceutical companies, contract research organizations (CROs), and academic and research institutions.

Tariffs have influenced the lentiviral vector market by increasing the cost of imported raw materials, reagents, and consumables critical for vector production. These tariffs have primarily affected regions in North America and Europe, where significant imports of kits and reagents originate from Asia-Pacific manufacturing hubs. The most impacted segments include lentiviral vector production kits and packaging reagents, which face cost escalation and potential supply delays. However, tariffs have also incentivized local manufacturing initiatives and supply chain diversification, leading to more resilient production networks and potential long-term cost optimization.

The lentiviral vector market research report is one of a series of new reports from The Business Research Company that provides lentiviral vector market statistics, including lentiviral vector industry global market size, regional shares, competitors with a lentiviral vector market share, detailed lentiviral vector market segments, market trends and opportunities, and any further data you may need to thrive in the lentiviral vector industry. This lentiviral vector market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lentiviral vector market size has grown rapidly in recent years. It will grow from $16.48 billion in 2025 to $18.95 billion in 2026 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to development of stable lentiviral production methods, increasing prevalence of genetic disorders, growth in academic and clinical research, rising investments in gene therapy R&D, availability of transduction and packaging kits.

The lentiviral vector market size is expected to see rapid growth in the next few years. It will grow to $30.66 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to expansion of gene therapy pipelines, adoption of automated vector production systems, collaborations between biotech and pharma companies, emergence of novel lentiviral vector applications, increased demand from emerging markets. Major trends in the forecast period include gene therapy adoption growth, viral vector engineering advancements, regulatory compliance & approval acceleration, increased research funding for genetic disorders, expansion of contract manufacturing capabilities.

The rising prevalence of chronic diseases is expected to drive the growth of the lentiviral vectors market in the coming years. Chronic diseases are long-term medical conditions that typically progress slowly and often persist for years or even a lifetime. Factors such as aging populations, unhealthy lifestyles, urbanization, and environmental influences are contributing to the increasing prevalence of these conditions. Lentiviral vectors provide versatile and efficient tools for developing vaccines and therapeutic strategies for chronic diseases, addressing unmet medical needs and improving patient outcomes. For instance, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including around 4 million males and 3.6 million females. These conditions account for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths per day, equating to one death every three minutes. Therefore, the increasing prevalence of chronic diseases is contributing to the growth of the lentiviral vectors market.

Major companies operating in the lentiviral vectors market are focusing on developing LV vector production platforms, such as LentiSure, to improve the efficiency and reliability of producing lentiviral vectors for cell-based immuno-oncology therapies. LentiSure is an LV vector production platform designed to enhance both efficiency and robustness in generating lentiviral vectors for therapeutic applications. For instance, in May 2023, Yposkesi SK pharmteco, a France-based viral vector manufacturer, launched LentiSure, an advanced platform aimed at improving the production of lentiviral (LV) vectors. This platform addresses the growing demand for robust and economically scalable viral-vector manufacturing technologies in cell and gene therapies. It provides consistent product quality, achieving average titers of 10e7 IG/mL at cell culture harvest in bioreactor volume, ensuring higher productivity and success for cell therapy developers.

In September 2024, Kyverna Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, entered into a license and supply agreement for the LentiVector platform with Oxford Biomedica. This collaboration allows Kyverna to utilize Oxford Biomedica's proprietary lentiviral vector technology for the development of gene therapies, particularly for autoimmune diseases. The agreement supports growth and innovation in the lentiviral vector market by providing a scalable and reliable vector supply to meet increasing demand. Oxford Biomedica, a UK-based biotechnology company, specializes in providing lentiviral vector platforms.

Major companies operating in the lentiviral vector market are Thermo Fisher Scientific Inc., Lonza Group AG, Cytiva, Takara Bio Inc., Promega Corporation, Bio-Rad Laboratories Inc., Merck KGaA, Agilent Technologies Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi, Applied Biological Materials Inc., OriGene Technologies Inc., Sino Biological Inc., Charles River Laboratories, Vigene Biosciences, VectorBuilder, Cell Biolabs Inc., Addgene, GeneCopoeia Inc.

North America was the largest region in the lentiviral vector market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lentiviral vector market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lentiviral vector market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lentiviral vector market consists of sales of 3rd generation lentiviral vectors, Lenti-ORF clones, and lentiviral particles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lentiviral Vector Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lentiviral vector market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lentiviral vector ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lentiviral vector market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Kits; Reagents And Consumables
• 2) By Indication: Cancer; Genetic Disorder; Infectious Disease; Veterinary Disease; Other Indications
• 3) By End User: Biotechnology Companies; Pharmaceutical Companies; Contract Research Organization (CRO); Academic And Research Institutes
• Subsegments:
• 1) By Kits: Lentiviral Transduction Kits; Lentiviral Packaging Kits; Lentiviral Vector Production Kits
• 2) By Reagents and Consumables: Lentiviral Packaging Reagents; Lentiviral Vector Concentration Reagents; Transfection Reagents for Lentiviral Vectors
• Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; Cytiva; Takara Bio Inc.; Promega Corporation; Bio-Rad Laboratories Inc.; Merck KGaA; Agilent Technologies Inc.; Oxford Biomedica; Sirion-Biotech GmbH; Yposkesi; Applied Biological Materials Inc.; OriGene Technologies Inc.; Sino Biological Inc.; Charles River Laboratories; Vigene Biosciences; VectorBuilder; Cell Biolabs Inc.; Addgene; GeneCopoeia Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Lentiviral Vector Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Lentiviral Vector Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Lentiviral Vector Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Lentiviral Vector Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Gene Therapy Adoption Growth
  • 4.2.2 Viral Vector Engineering Advancements
  • 4.2.3 Regulatory Compliance & Approval Acceleration
  • 4.2.4 Increased Research Funding For Genetic Disorders
  • 4.2.5 Expansion Of Contract Manufacturing Capabilities

5. Lentiviral Vector Market Analysis Of End Use Industries

• 5.1 Biotechnology Companies
• 5.2 Pharmaceutical Companies
• 5.3 Contract Research Organizations (Cros)
• 5.4 Academic And Research Institutes
• 5.5 Gene Therapy Clinics

6. Lentiviral Vector Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lentiviral Vector Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Lentiviral Vector PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Lentiviral Vector Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Lentiviral Vector Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Lentiviral Vector Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lentiviral Vector Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lentiviral Vector Market Segmentation

• 9.1. Global Lentiviral Vector Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Kits, Reagents And Consumables
• 9.2. Global Lentiviral Vector Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
• 9.3. Global Lentiviral Vector Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes
• 9.4. Global Lentiviral Vector Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lentiviral Transduction Kits, Lentiviral Packaging Kits, Lentiviral Vector Production Kits
• 9.5. Global Lentiviral Vector Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lentiviral Packaging Reagents, Lentiviral Vector Concentration Reagents, Transfection Reagents for Lentiviral Vectors

10. Lentiviral Vector Market Regional And Country Analysis

• 10.1. Global Lentiviral Vector Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Lentiviral Vector Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lentiviral Vector Market

• 11.1. Asia-Pacific Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lentiviral Vector Market

• 12.1. China Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lentiviral Vector Market

• 13.1. India Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lentiviral Vector Market

• 14.1. Japan Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lentiviral Vector Market

• 15.1. Australia Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lentiviral Vector Market

• 16.1. Indonesia Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lentiviral Vector Market

• 17.1. South Korea Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lentiviral Vector Market

• 18.1. Taiwan Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lentiviral Vector Market

• 19.1. South East Asia Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lentiviral Vector Market

• 20.1. Western Europe Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lentiviral Vector Market

• 21.1. UK Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lentiviral Vector Market

• 22.1. Germany Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lentiviral Vector Market

• 23.1. France Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lentiviral Vector Market

• 24.1. Italy Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lentiviral Vector Market

• 25.1. Spain Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lentiviral Vector Market

• 26.1. Eastern Europe Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lentiviral Vector Market

• 27.1. Russia Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lentiviral Vector Market

• 28.1. North America Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lentiviral Vector Market

• 29.1. USA Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lentiviral Vector Market

• 30.1. Canada Lentiviral Vector Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lentiviral Vector Market

• 31.1. South America Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lentiviral Vector Market

• 32.1. Brazil Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lentiviral Vector Market

• 33.1. Middle East Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lentiviral Vector Market

• 34.1. Africa Lentiviral Vector Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Lentiviral Vector Market, Segmentation By Product Type, Segmentation By Indication, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lentiviral Vector Market Regulatory and Investment Landscape

36. Lentiviral Vector Market Competitive Landscape And Company Profiles

• 36.1. Lentiviral Vector Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Lentiviral Vector Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Lentiviral Vector Market Company Profiles
  • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Cytiva Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Promega Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Lentiviral Vector Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., Merck KGaA, Agilent Technologies Inc., Oxford Biomedica, Sirion-Biotech GmbH, Yposkesi, Applied Biological Materials Inc., OriGene Technologies Inc., Sino Biological Inc., Charles River Laboratories, Vigene Biosciences, VectorBuilder, Cell Biolabs Inc., Addgene, GeneCopoeia Inc.

38. Global Lentiviral Vector Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lentiviral Vector Market

40. Lentiviral Vector Market High Potential Countries, Segments and Strategies

• 40.1 Lentiviral Vector Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Lentiviral Vector Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Lentiviral Vector Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer